ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999

White House Expected To Nominate Nobel Laureate Harold Varmus As NCI Director

March 17, 2010

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976